Compound for the treatment and prevention of central nervous system disorders

A method of treating a central nervous system disorder in a subject in need thereof comprising a step of administration of a therapeutically effective amount of a pharmaceutical composition to said subject;

• wherein the pharmaceutical composition comprises a compound of formula (II)
• or a pharmaceutically acceptable salt and/or solvate thereof,
• wherein:
• R1, R2 and R11 are each independently C1-C3 alkyl,
• R3, R4, R5, R6, R7, R8, R9 and R10 are each independently selected from hydrogen, halogen, hydroxyl, —NH3, —NO3, —SH, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 alkoxy, and C1-C3 thioalkyl,
• R12, R13, R15 and R16 are each independently selected from hydrogen, halogen, hydroxyl, —NH3, —NO3, —SH, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 alkoxy, and C1-C3 thioalkyl, and
• R14 is C1-C3 alkyl,
• and at least one pharmaceutically acceptable excipient;
• wherein the central nervous system disorder comprises a neurological disorder selected from the group consisting of Epilepsy, Alzheimer's Disease (AD), Mild Cognitive Impairment (MCI), Attention-Deficit Hyperactivity Disorder (ADHD), Hyper-kinetic Disorder, agnosia, Amyotrophic Lateral Sclerosis (ALS), Huntington's disease, Lewy body disease, Parkinson's disease, Spinal muscular atrophy, ataxia, Canavan disease, dementia, neuralgia, migraine, headaches, and tension headaches.